SecBot SecBot
SC 13G/A ·Filed Oct 27, 2026

STAA

STAAR SURGICAL CO
NEUTRAL
Impact 2/10
Horizonweeks Processed4d 14h ago SEC0002012383-26-003941
Passive stake amendment
Actionable Insight • Neutral

Monitor future 13G amendments for any stake reduction below 5% or conversion to 13D, which would signal a change in investment approach. No immediate action warranted given the passive nature of the filing.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled: T+1d
STAA ▲ +2.56% at T+1d
NEUTRAL call +2.56% · α vs SPY +2.94% · entry $24.61 → $25.24
Next anchor: T+5d tomorrow
Entry = T+0 close
Oct 27, 2026
via day close
T+1d
+2.56%
call +2.56% · α +2.94%
$25.24
settled 4d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 23d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

BlackRock Inc. filed an amended Schedule 13G for STAAR SURGICAL CO, reporting beneficial ownership of 4,611,827 shares (9.2% of common stock) as of September 30, 2026. This is a routine passive stake update by a large index/asset manager; no change in investment intent or activist conversion is indicated.

Key Financial Metrics

Stake
9.2%
Stake Value
$101.2M
Investor
BlackRock, Inc.
Investor Type
index fund

Key Facts

  • BlackRock Inc. reported 4,611,827 shares of STAAR SURGICAL CO common stock, representing 9.2% of shares outstanding.
  • The filing is an amendment to Schedule 13G, confirming passive investment intent under Rule 13d-1(b).
  • The stake is held across multiple BlackRock subsidiaries; BlackRock Fund Advisors is the entity that beneficially owns 5% or more.
  • No prior stake percentage was provided in the current filing for comparison, but the market data snapshot shows BlackRock as the top 13F holder with $193M as of Q2 2026.

Financial Impact

BlackRock's 9.2% stake is valued at approximately $101M based on the $1.1B market cap snapshot.

ownership_percentage

Risk Factors

  • No material risks identified; this is a routine passive ownership update.

Market Snapshot

Exchange
Nasdaq
Sector
Ophthalmic Goods
Analyst Consensus
50% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0002012383-26-003941
Document: Item_7.txt0002012383-26-003941
Document: 0002012383-26-003941-index-headers.html0002012383-26-003941
Document: 0002012383-26-003941-index.html0002012383-26-003941
Document: 0002012383-26-003941.txt0002012383-26-003941
7 reports for STAA
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +18.79%Jun 11, 2026
Filters
Rows
Reports for STAA, sortable and filterable
TypeNow
Oct 27, 2026
4d ago
SC 13G/A
NEUTRAL ★ 2/10
$24.61awaiting T+60awaiting T+60$24.54 (−0.28%)
Aug 12, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$25.33awaiting T+60awaiting T+60$24.54 (−3.12%)
Aug 6, 2026
12w ago
8-K
NEUTRAL ★ 3/10
$23.12 $25.24▲ +9.17%▲ +10.60%$24.54 (+6.14%)
Jun 22, 2026
18w ago
8-K
NEUTRAL ★ 3/10
$28.36 $22.41▼ −20.98%▼ −24.23%$24.54 (−13.47%)
Jun 11, 2026
20w ago
Institutional Cluster
BEARISH ★ 5/10
$28.90 $23.47▲ +18.79%▲ +23.18%$24.54 (+15.09%)
May 13, 2026
24w ago
8-K
BULLISH ★ 8/10
$32.01 $25.12▼ −21.52%▼ −25.11%$24.54 (−23.34%)
Apr 8, 2026
29w ago
8-K
BULLISH ★ 7/10
$25.21 $27.34▲ +8.45%▼ −2.33%$24.54 (−2.66%)
Showing 7 of 7

US Market Status

Market Closed · Opens Mon (26h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026